tiprankstipranks
Trending News
More News >
Passage Bio (PASG)
NASDAQ:PASG
US Market

Passage Bio (PASG) Income Statement

Compare
530 Followers

Passage Bio Income Statement

Last quarter (Q4 2024), Passage Bio's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Passage Bio's net income was $-12.72M. See Passage Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -3.72M$ -3.68M$ -1.54M$ -800.00K
Operating Expenses
$ 65.17M$ 108.39M$ 135.39M$ 177.73M$ 111.90M
Depreciation and Amortization
$ 0.00$ 3.72M$ 3.68M$ 1.54M$ 800.00K
EBITDA
$ -70.40M$ -98.34M$ -138.39M$ -185.73M$ -112.90M
Operating Income
$ -70.40M$ -108.39M$ -138.39M$ -185.73M$ -112.90M
Other Income/Expenses
$ 5.63M$ 6.33M$ 2.27M$ 343.00K$ 670.00K
Pretax Income
$ -64.77M$ -102.06M$ -136.13M$ -185.39M$ -112.23M
Net Income
$ -64.77M$ -102.06M$ -136.86M$ -191.50M$ -111.76M
Per Share Metrics
Basic EPS
$ -1.07$ -1.86$ -2.51$ -3.59$ -2.89
Diluted EPS
$ -1.07$ -1.86$ -2.51$ -3.59$ -2.89
Weighted Average Shares Outstanding
60.41M 54.74M 54.43M 53.34M 38.62M
Weighted Average Shares Outstanding (Diluted)
60.41M 54.74M 54.43M 53.34M 38.62M
Currency in USD

Passage Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis